World Investment Advisors LLC purchased a new position in Cabot Co. (NYSE:CBT - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 28,278 shares of the specialty chemicals company's stock, valued at approximately $3,161,000. World Investment Advisors LLC owned approximately 0.05% of Cabot as of its most recent SEC filing.
A number of other institutional investors also recently added to or reduced their stakes in CBT. Wolff Wiese Magana LLC bought a new stake in shares of Cabot in the 3rd quarter worth about $25,000. CWM LLC grew its stake in Cabot by 60.6% during the second quarter. CWM LLC now owns 416 shares of the specialty chemicals company's stock worth $38,000 after buying an additional 157 shares during the last quarter. UMB Bank n.a. increased its holdings in shares of Cabot by 53.9% during the third quarter. UMB Bank n.a. now owns 371 shares of the specialty chemicals company's stock worth $41,000 after buying an additional 130 shares in the last quarter. Farther Finance Advisors LLC raised its stake in shares of Cabot by 197.9% in the third quarter. Farther Finance Advisors LLC now owns 417 shares of the specialty chemicals company's stock valued at $47,000 after acquiring an additional 277 shares during the last quarter. Finally, EverSource Wealth Advisors LLC grew its position in Cabot by 33.4% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 475 shares of the specialty chemicals company's stock worth $48,000 after acquiring an additional 119 shares during the last quarter. 93.18% of the stock is owned by institutional investors and hedge funds.
Insiders Place Their Bets
In other news, CAO Lisa M. Dumont sold 865 shares of the business's stock in a transaction dated Wednesday, November 13th. The stock was sold at an average price of $111.74, for a total transaction of $96,655.10. Following the completion of the transaction, the chief accounting officer now directly owns 9,742 shares in the company, valued at approximately $1,088,571.08. The trade was a 8.15 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Hobart Kalkstein sold 34,759 shares of the stock in a transaction that occurred on Monday, November 11th. The shares were sold at an average price of $115.23, for a total transaction of $4,005,279.57. Following the completion of the sale, the executive vice president now owns 50,627 shares in the company, valued at $5,833,749.21. This represents a 40.71 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 50,190 shares of company stock valued at $5,751,534. Company insiders own 3.07% of the company's stock.
Cabot Trading Down 0.7 %
Shares of CBT stock traded down $0.71 on Friday, reaching $103.38. 396,741 shares of the stock were exchanged, compared to its average volume of 345,833. The company has a debt-to-equity ratio of 0.68, a current ratio of 2.08 and a quick ratio of 1.36. Cabot Co. has a one year low of $70.63 and a one year high of $117.46. The stock has a market cap of $5.62 billion, a PE ratio of 15.34, a P/E/G ratio of 0.90 and a beta of 1.18. The stock has a 50 day moving average price of $110.25 and a 200 day moving average price of $103.29.
Cabot (NYSE:CBT - Get Free Report) last announced its quarterly earnings data on Monday, November 4th. The specialty chemicals company reported $1.80 earnings per share for the quarter, missing the consensus estimate of $1.81 by ($0.01). The firm had revenue of $1 billion for the quarter, compared to the consensus estimate of $1.01 billion. Cabot had a return on equity of 26.60% and a net margin of 9.51%. The business's revenue for the quarter was up 3.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.65 earnings per share. Equities research analysts forecast that Cabot Co. will post 7.67 EPS for the current fiscal year.
Cabot declared that its Board of Directors has initiated a stock buyback plan on Tuesday, December 3rd that allows the company to repurchase 10,000,000 shares. This repurchase authorization allows the specialty chemicals company to repurchase shares of its stock through open market purchases. Stock repurchase plans are generally a sign that the company's board believes its shares are undervalued.
Cabot Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, December 13th. Shareholders of record on Friday, November 29th were paid a $0.43 dividend. The ex-dividend date was Friday, November 29th. This represents a $1.72 dividend on an annualized basis and a yield of 1.66%. Cabot's payout ratio is presently 25.52%.
Analyst Upgrades and Downgrades
A number of equities analysts have commented on the company. Mizuho boosted their price objective on Cabot from $103.00 to $122.00 and gave the stock an "outperform" rating in a research note on Tuesday, November 5th. JPMorgan Chase & Co. cut shares of Cabot from a "neutral" rating to an "underweight" rating and set a $105.00 price objective for the company. in a research report on Monday, November 11th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $105.00.
View Our Latest Report on CBT
Cabot Company Profile
(
Free Report)
Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
Recommended Stories
Before you consider Cabot, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cabot wasn't on the list.
While Cabot currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.